Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
Lai urges greater transparency in officials' China exchanges
03/13/2025 10:41 PM - Society
Record compensation approved in Polam Kopitiam food poisoning case
03/13/2025 10:10 PM - Politics
Lai seeks to reinstate military trials amid growing Chinese infiltration
03/13/2025 09:52 PM - Politics
Control Yuan censures Taipei transit dept. for post-quake line damage
03/13/2025 09:47 PM - Society
Domestic violence sentence reduced to negligence in basketball star case
03/13/2025 09:04 PM